Immune Design
Immune Design Corp. (IDC) uses breakthrough technology to develop safe and effective vaccines and therapeutics, with emphasis on the prevention and treatment of infectious disease. This goal is being achieved through dedicated research aimed towards a greater understanding of the immune system, and by developing a new generation of immune-based products for the pharmaceutical industry. IDC is passionate about its mission to alleviate human suffering and pursues this goal with high energy and an unsurpassed standard of excellence
Industries
biotechnology
health-care
therapeutics
Nr. of Employees
small (1-50)
Immune Design
Seattle, Washington, United States, North America
Patents
Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof
US-11365230-B2
View DetailsRetroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids
US-11135283-B2
View DetailsMultigenome retroviral vector preparations and methods and systems for producing and using same
US-10584356-B2
View Details
Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof
US-11365230-B2
View DetailsRetroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids
US-11135283-B2
View DetailsMultigenome retroviral vector preparations and methods and systems for producing and using same
US-10584356-B2
View Details